Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	10.60	55.04	49.76
Graham Fair Price	31.12	14.64	11.16
PEG	-11.40	0.47	-0.53
Price/Book	-11.93	1.78	2.02
Price/Cash Flow	83.36	-26.54	-159.51
Prices/Earnings	-27.65	21.76	30.08
Price/Sales	0.12	6.70	6.69
Price/FCF	83.36	-26.54	-159.51
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-58.17	0.28	0.67
Operating Margin	3.12	0.19	0.18
ROA	37.44	< 0.005	< 0.005
ROE	0.02	0.02	21.71
ROIC	0.01	0.01	-5.06
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.02	0.02	-14.96
Dividends QOQ	0.06	< 0.005	-93.45
EBIT QOQ	-0.15	0.08	-47.36
EPS QOQ	-0.57	0.47	-18.33
FCF QOQ	0.36	-5.29	1372.03
Revenue QOQ	-0.10	0.04	-54.17
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	44.56	20.48	-54.04
Days Sales Outstanding (DSO)	45.31	58.02	28.04
Inventory Turnover	2.02	4.39	117.58
Debt/Capitalization	0.70	0.66	-5.76
Quick Ratio	0.32	0.48	51.37
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	18.17	21.60	18.85
Cash	0.24	1.59	568.27
Capex	-1.90	-1.38	27.48
Free Cash Flow	-0.23	-1.45	-529.16
Revenue	5.48	5.73	4.54
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.48	0.65	35.84
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	26.90	28.47	5.84
Naive Interpretation	Member

06 - Financial Health · Bad

Rating